Hologic Executive and Leadership Team

Karleen Oberton, the Chief Financial Officer at Hologic, manages the fiscal health and capital allocation strategies that fuel the company's medical technology innovation. Oberton oversees financial planning, reporting, and investor relations to ensure sustainable growth across the breast health and diagnostic portfolios. By maintaining rigorous financial discipline, the Chief Financial Officer supports the development of advanced imaging systems and surgical tools. This leadership role requires constant monitoring of global market trends to mitigate risks and capitalize on expansion opportunities. Karleen Oberton drives long-term value creation by aligning budgetary resources with the strategic goal of enhancing patient care standards. Through precise financial modeling and operational oversight, the Chief Financial Officer ensures that Hologic possesses the necessary capital to invest in research and development. Oberton secures the financial foundation required for the company to maintain its position as a global leader in women's health diagnostics and treatment.

Essex Mitchell, the Chief Operating Officer at Hologic, directs the global supply chain and manufacturing processes that deliver critical medical diagnostic products to healthcare providers. Mitchell architects efficient production workflows to ensure the consistent availability of imaging systems and surgical tools. By optimizing operational logistics, the Chief Operating Officer maintains high standards of quality control across all manufacturing facilities. This leadership role involves coordinating with regional teams to streamline distribution and improve service delivery in diverse healthcare environments. Essex Mitchell drives operational excellence by implementing lean manufacturing principles that reduce waste and increase output capacity. Through the management of complex global operations, the Chief Operating Officer ensures that Hologic meets the urgent demands of clinical care providers. Mitchell oversees the integration of new technologies into the production line, ensuring that the company remains at the forefront of medical device manufacturing and patient-focused innovation.

Jennifer Schneiders, the President, Diagnostic Solutions at Hologic, leads the development and commercialization of advanced infectious disease testing and gynecological diagnostic platforms. Schneiders architects the strategic roadmap for the diagnostic division, focusing on early detection technologies that improve patient outcomes. By overseeing the entire product lifecycle, the President, Diagnostic Solutions ensures that clinical care teams receive accurate and timely diagnostic data. This leadership role involves navigating complex regulatory landscapes and fostering partnerships with healthcare institutions to expand the reach of testing solutions. Jennifer Schneiders drives innovation within the diagnostic portfolio, pushing the boundaries of molecular testing and laboratory efficiency. Through the management of research and commercial teams, the President, Diagnostic Solutions supports the company's mission to raise standards of care. Schneiders ensures that Hologic remains a trusted partner for clinicians by delivering reliable, high-performance diagnostic tools that address critical health challenges in the global market.

Horvath Mark, the President, Breast & Skeletal Health Solutions at Hologic, directs the innovation and market strategy for the company's flagship breast imaging and bone health systems. Mark architects the development of advanced mammography and surgical guidance tools that define the standard for early breast cancer detection. By overseeing the product portfolio, the President, Breast & Skeletal Health Solutions ensures that healthcare professionals have access to the most precise imaging technology available. This leadership role involves driving clinical adoption and expanding the footprint of skeletal health solutions in major medical markets. Horvath Mark drives the strategic vision for the division, focusing on technological advancements that improve diagnostic accuracy and patient comfort. Through the management of specialized research and sales teams, the President, Breast & Skeletal Health Solutions supports the company's commitment to women's health. Mark ensures that Hologic continues to lead the industry in breast and skeletal health innovation.

Jan Verstreken, the Group President, International at Hologic, directs the company's commercial expansion and operational strategy across all markets outside the United States. Verstreken architects regional growth plans that adapt diagnostic and surgical solutions to the specific needs of diverse healthcare systems. By overseeing international sales and distribution networks, the Group President, International ensures that Hologic maintains a strong presence in global medical communities. This leadership role involves building strategic alliances with international health authorities and clinical leaders to promote the adoption of advanced medical technologies. Jan Verstreken drives the execution of global initiatives, ensuring that the company's mission reaches patients in various geographic regions. Through the management of cross-border operations, the Group President, International facilitates the delivery of high-quality care standards worldwide. Verstreken ensures that Hologic remains a dominant force in the international medical technology sector by fostering local partnerships and driving sustainable market penetration.

Paul Malenchini, the Chief Information Officer at Hologic, directs the enterprise digital infrastructure and cybersecurity frameworks necessary for global medical technology operations. Malenchini architects scalable data systems that support diagnostic product development and clinical care workflows. By integrating advanced analytics into the corporate ecosystem, the Chief Information Officer optimizes internal efficiency and protects sensitive patient information across all digital platforms. This leadership role involves collaborating with cross-functional teams to ensure technological alignment with the broader mission of improving women's health. Paul Malenchini drives the digital transformation agenda, ensuring that Hologic maintains a competitive edge in the rapidly evolving medical device landscape. Through the implementation of robust cloud solutions and secure network architectures, the Chief Information Officer facilitates seamless communication between research facilities and clinical partners worldwide, ultimately strengthening the company's ability to deliver life-saving diagnostic tools.